down arrow

Panacea Biotec

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE922B01023
  • NSEID: PANACEABIO
  • BSEID: 531349
INR
452.90
16.95 (3.89%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 1.09 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Dec'18
Net Sales
426.56
422.71
331.02
520.50
456.54
418.70
329.99
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
426.56
422.71
331.02
520.50
456.54
418.70
329.99
Raw Material Cost
130.75
164.93
151.52
228.92
137.17
136.26
66.11
Purchase of Finished goods
0.15
2.29
7.26
25.00
7.99
8.43
6.53
(Increase) / Decrease In Stocks
16.56
13.15
36.40
-60.82
0.59
-21.29
25.27
Employee Cost
123.92
111.14
95.93
135.81
111.79
104.28
109.00
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
-6.16
-4.56
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
154.21
145.22
132.20
175.26
123.30
142.95
127.70
Total Expenditure (Excl Depreciation)
425.59
436.73
423.31
504.17
380.84
364.47
330.05
Operating Profit (PBDIT) excl Other Income
0.97
-14.02
-92.29
16.33
75.70
54.23
-0.06
Other Income
12.07
14.99
36.60
6.92
5.08
11.71
7.97
Operating Profit (PBDIT)
13.04
0.97
-55.69
23.25
80.78
65.94
7.91
Interest
2.84
2.76
3.39
150.18
138.43
129.52
40.65
Exceptional Items
8.28
33.29
83.28
0.00
0.00
-15.40
-26.84
Gross Profit (PBDT)
18.48
31.50
24.20
-126.93
-57.65
-78.98
-59.58
Depreciation
26.39
27.90
29.61
32.51
34.02
33.17
79.13
Profit Before Tax
-7.91
3.60
-5.41
-159.44
-91.67
-112.15
-138.71
Tax
-1.18
3.11
15.66
0.04
0.47
7.49
5.11
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
-6.73
0.49
-21.07
-159.48
-92.14
-119.64
-143.82
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
-1.45
-5.12
-4.44
Net Profit
-6.73
0.49
-21.07
-159.48
-93.59
-124.76
-148.26
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.08
0.17
0.06
Minority Interest
-0.08
0.08
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
-6.65
0.41
-21.07
-159.48
-93.51
-124.59
-148.20
Equity Capital
6.13
6.13
6.13
6.13
6.13
6.13
6.13
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
0.74
-0.37
3.16
-8.03
-6.54
-3.48
-2.62
Operating Profit Margin (Excl OI)
0.23%
-3.32%
-27.88%
3.14%
16.58%
12.95%
-0.02%
Gross Profit Margin
4.33%
7.45%
7.31%
-24.39%
-12.63%
-18.86%
-18.06%
PAT Margin
-1.58%
0.12%
-6.37%
-30.64%
-20.18%
-28.57%
-43.58%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is 0.91% vs 27.70% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is -1,721.95% vs 101.95% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is 106.92% vs 84.81% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 2.90% vs -18.58% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023

Compare Nine Monthly Results Of Panacea Biotec With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
426.56
9,199.93
-8,773.37
-95.36%
Other Operating Income
0.00
0.00
0.00
Total Operating income
426.56
9,199.93
-8,773.37
-95.36%
Raw Material Cost
130.75
1,471.08
-1,340.33
-91.11%
Purchase of Finished goods
0.15
1,244.57
-1,244.42
-99.99%
(Increase) / Decrease In Stocks
16.56
-93.01
109.57
117.80%
Employee Cost
123.92
1,989.92
-1,866.00
-93.77%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
154.21
2,225.77
-2,071.56
-93.07%
Total Expenditure (Excl Depreciation)
425.59
6,838.33
-6,412.74
-93.78%
Operating Profit (PBDIT) excl Other Income
0.97
2,361.60
-2,360.63
-99.96%
Other Income
12.07
287.35
-275.28
-95.80%
Operating Profit (PBDIT)
13.04
2,648.95
-2,635.91
-99.51%
Interest
2.84
238.94
-236.10
-98.81%
Exceptional Items
8.28
0.00
8.28
Gross Profit (PBDT)
18.48
2,410.01
-2,391.53
-99.23%
Depreciation
26.39
405.66
-379.27
-93.49%
Profit Before Tax
-7.91
2,007.79
-2,015.70
-100.39%
Tax
-1.18
427.80
-428.98
-100.28%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
-6.73
1,576.55
-1,583.28
-100.43%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
-6.73
1,576.55
-1,583.28
-100.43%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
-0.08
-7.70
7.62
98.96%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
-6.65
1,570.19
-1,576.84
-100.42%
Equity Capital
6.13
40.06
-33.93
-84.70%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
4.33%
26.20%
0.00
-21.87%
PAT Margin
-1.58%
17.14%
0.00
-18.72%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 426.56 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 0.91% vs 27.70% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit -6.65 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -1,721.95% vs 101.95% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 0.97 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 106.92% vs 84.81% in Dec 2023

Nine Monthly - Interest
Interest 2.84 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 2.90% vs -18.58% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 0.23%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has improved from Dec 2023